These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 21206546)
1. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study. Gooneratne NS; Gehrman P; Gurubhagavatula I; Al-Shehabi E; Marie E; Schwab R J Clin Sleep Med; 2010 Dec; 6(6):572-80. PubMed ID: 21206546 [TBL] [Abstract][Full Text] [Related]
2. Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. Kryger M; Wang-Weigand S; Roth T Sleep Breath; 2007 Sep; 11(3):159-64. PubMed ID: 17294232 [TBL] [Abstract][Full Text] [Related]
3. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia. Roth T; Seiden D; Wang-Weigand S; Zhang J Curr Med Res Opin; 2007 May; 23(5):1005-14. PubMed ID: 17519067 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. Zammit G; Erman M; Wang-Weigand S; Sainati S; Zhang J; Roth T J Clin Sleep Med; 2007 Aug; 3(5):495-504. PubMed ID: 17803013 [TBL] [Abstract][Full Text] [Related]
5. The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease. Kryger M; Roth T; Wang-Weigand S; Zhang J Sleep Breath; 2009 Mar; 13(1):79-84. PubMed ID: 18584227 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Ramelteon on Heartburn Symptoms of Patients With Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study. Jha LK; Fass R; Gadam R; Maradey-Romero C; Nasrollah L; Hershcovici T; Quan SF; Dickman R J Clin Gastroenterol; 2016 Feb; 50(2):e19-24. PubMed ID: 25887111 [TBL] [Abstract][Full Text] [Related]
7. Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis. Wang-Weigand S; McCue M; Ogrinc F; Mini L Curr Med Res Opin; 2009 May; 25(5):1209-13. PubMed ID: 19327100 [TBL] [Abstract][Full Text] [Related]
8. The effects of ramelteon in a first-night model of transient insomnia. Zammit G; Schwartz H; Roth T; Wang-Weigand S; Sainati S; Zhang J Sleep Med; 2009 Jan; 10(1):55-9. PubMed ID: 18691937 [TBL] [Abstract][Full Text] [Related]
9. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464 [TBL] [Abstract][Full Text] [Related]
10. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect. Mini L; Wang-Weigand S; Zhang J Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955 [TBL] [Abstract][Full Text] [Related]
12. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. Mini LJ; Wang-Weigand S; Zhang J Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia. Kohsaka M; Kanemura T; Taniguchi M; Kuwahara H; Mikami A; Kamikawa K; Uno H; Ogawa A; Murasaki M; Sugita Y Expert Rev Neurother; 2011 Oct; 11(10):1389-97. PubMed ID: 21955196 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia. Uchiyama M; Hamamura M; Kuwano T; Nishiyama H; Nagata H; Uchimura N Sleep Med; 2011 Feb; 12(2):119-26. PubMed ID: 21256803 [TBL] [Abstract][Full Text] [Related]
16. Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study. Richardson GS; Zammit G; Wang-Weigand S; Zhang J J Clin Psychiatry; 2009 Apr; 70(4):467-76. PubMed ID: 19284927 [TBL] [Abstract][Full Text] [Related]
17. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Erman M; Seiden D; Zammit G; Sainati S; Zhang J Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958 [TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of an integrated approach to treating insomnia and improving the use of positive airway pressure therapy in veterans with comorbid insomnia disorder and obstructive sleep apnea. Alessi CA; Fung CH; Dzierzewski JM; Fiorentino L; Stepnowsky C; Rodriguez Tapia JC; Song Y; Zeidler MR; Josephson K; Mitchell MN; Jouldjian S; Martin JL Sleep; 2021 Apr; 44(4):. PubMed ID: 33221910 [TBL] [Abstract][Full Text] [Related]
19. The Effectiveness of Nasal Airway Stent Therapy for the Treatment of Mild-to-Moderate Obstructive Sleep Apnea Syndrome. Ohtsuka K; Baba R; Yamasawa W; Shirahama R; Hattori Y; Senoura H; Betsuyaku T; Fukunaga K Respiration; 2021; 100(3):193-200. PubMed ID: 33370725 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial. Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]